Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Current Cash

The latest current cash for DMAQR is $6.4M as of June 2026. That compares with $8.1M in the prior-year period — down 20.9% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Tradeable Rights - Oct 2026's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQR's current cash moved from $8.1M to $6.4M — a 20.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Tradeable Rights - Oct 2026's operating scale or balance-sheet position.

A current cash figure of $6.4M for DMAQR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQR's current cash ($6.4M), review year-over-year change from $8.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.